We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Axis-Shield | LSE:ASD | London | Ordinary Share | GB0008039975 | ORD 35P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 469.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Sep 2019 to Sep 2024
TIDMASD
RNS Number : 1930S
Axis-Shield PLC
16 November 2011
AXIS-SHIELD PLC
DIRECTORATE CHANGES
Dundee, Scotland, 16 November 2011. Axis-Shield plc (LSE:ASD, OSE:ASD) ("Axis-Shield") today announces that Bay Green, Staffan Ek and Prof. Wenche Rolfsen have resigned from the Board of Axis-Shield with immediate effect.
Dr. John Brown, Non-Executive Chairman of Axis-Shield, commented: "We are extremely grateful to Bay, Staffan and Wenche for their valuable advice and guidance during the growth of Axis-Shield. We wish them every success in their future endeavours."
-Ends-
For further enquiries, please contact:
Hot Features
Premium
Axis-Shield plc
Ian Gilham, Chief Executive Officer Tel: +44 203 178 7849
Ronny Hermansen, Finance Director
M:Communications
Peter Laing / Emma Thompson / Tel: +44 207 920 2330
Claire Dickinson E-mail: axisshield@mcomgroup.com
Corporate Communications (Norway)
Geir Bjorlo / Hakon Ronning Tel: +47 23 89 89
30
Notes for Editors
About Axis-Shield
Headquartered in Dundee with R&D and manufacturing facilities in Dundee and Oslo, Axis-Shield is a leading international and innovative company operating in faster growing segments of the in vitro diagnostics (IVD) market. Axis-Shield provides point-of-care testing via its Afinion(TM) and NycoCard(R) instruments and also serves the clinical laboratory through the development of novel tests, particularly for the high throughput analysers of blue-chip original equipment manufacturers (OEMs). The Company has a strong franchise in the diabetes testing market and is developing a cholesterol/lipid panel for testing at the point-of-care, both major areas for future growth. Through its Direct Distribution division, Axis-Shield also markets its own and other third-party products including medical devices to end users in key markets including the USA, Germany, Switzerland, the UK and the Nordic region. For more information on Axis-Shield, please refer to www.axis-shield.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOALIFVALSLRLIL
1 Year Axis-shield Chart |
1 Month Axis-shield Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
